Lucence: Chao Xie

Aug 27, 2020

Singapore-based precision oncology company Lucence has appointed Chao Xie as chief data scientist to develop advanced analytics of ultrasensitive liquid biopsy diagnostics for cancer. Xie previously served as head of data science at AirAsia. He won a US Defense Threat Reduction Agency $1M global competition in 2013 for designing an algorithm to rapidly and accurately identify dangerous viruses and bacteria in gene sequencing data.

Breaking News

Acutis Diagnostics to Integrate Sophia Genetics Analytics Into Hereditary Cancer NGS Assay
Reactivated Promoters in Transposable Elements Help Form Unique Tumor Antigens
Breast Cancer Study Leads to New Susceptibility Gene, Potential Treatment Strategies
Lucira Health Combo Flu/COVID-19 MDx Test Gets Regulatory Approval in Australia
Atrandi Biosciences Raises $4.8M to Advance Commercialization of Single-Cell Microfluidics Tech

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.